Entities

MacAndrews & Forbes

Entity Type
Founding Date
1850

MacAndrews & Forbes Incorporated is a private holding company that spans a wide range of industries—from global leaders in cosmetics to biotechnology and military equipment. Founded in 1850, the company aims to build, run, and grow great businesses. The company owns and operates a diverse array of businesses to support the delivery of best-in-class products and services to end users and consumers all over the world.

ABOUT MACANDREWS & FORBES

  • MacAndrews & Forbes is primarily known for acquiring and managing a diverse portfolio of companies.

  • Throughout the years, the company has invested in a variety of industries, including pharmaceuticals, media, and consumer products.

  • The company operates through its subsidiaries, often taking a hands-on approach to managing the companies in which it has a significant stake.


PORTFOLIO

  • Vericast. 

An FI performance partner that helps banks and credit unions drive growth, improve efficiency, increase engagement and navigate change through the power of data, technology, and people.

  • VTV Therapeutics. 

A clinical-stage biotechnology company that was granted Breakthrough Therapy designation by the U.S. Food and Drug Administration in April 2021.

  • SIGA Technologies. 

SIGA is a leader in providing solutions for unmet needs in the estimated $10 billion global health security market.


NOTABLE INVESTMENTS

  • Revlon. 

One of its most prominent investments is in Revlon, the cosmetics and personal care brand. The company has faced challenges in recent years but remains a significant part of MacAndrews & Forbes' portfolio.

  • Scientific Games. 

Another key investment is in Scientific Games, a global leader in gaming technology, particularly in lottery and casino gaming solutions. 

  • Coleman. 

MacAndrews & Forbes also had an investment in Coleman, the outdoor equipment company, and has been involved in consolidating brands under its portfolio to optimize operations.

  • Allergan. 

While not directly owned by MacAndrews & Forbes, the firm has been involved in a series of investments in pharmaceutical companies.